Phase 1/2A Study of Glutathione Pegylated Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (Bm) from Solid Tumors or Recurrent High Grade Gliomas (Hgg)Dieta Brandsma, Philippe Aftimos, Bojana Milojkovic Kerklaan et al.|Annals of Oncology|2014Cited by 33
NT-23 * PHASE 1/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG)Bojana Milojkovic Kerklaan, Dieta Brandsma, Agnes Jager et al.|Neuro-Oncology|2014Cited by 14
P08.03 * 2B3-101, GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMAS AND BREAST CANCER BRAIN METASTASESDieta Brandsma, Philippe Aftimos, Véronique Dièras et al.|Neuro-Oncology|2014Cited by 11
Surgical safety of immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib. Data from the EORTC randomized trial 30073 SURTIMEAxel Bex, John Haanen, T. Powles et al.|European Urology Supplements|2018Cited by 7
Abstract P6-16-04: Phase 1/2a study of glutathione PEGylated liposomal doxorubicin (2B3-101) in breast cancer patients with brain metastasesPhilippe Aftimos, Dieta Brandsma, Bojana Milojkovic-Kerklaan et al.|Cancer Research|2015Cited by 6